Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Evaluation of IL-2 and Dexamethasone intracavitary injection on the management of malignant effusion in children with solid tumors or lymphoma

Fig. 3

A: The Kaplan Meier analysis demonstrated significant differences between the effusion group and control group for pediatric cancer patients in EFS (p < 0.01). The hazard ratio was 0.352 for EFS. A: The Kaplan Meier analysis demonstrated significant differences between the effusion group and control group for pediatric cancer patients in OS (p < 0.01). The hazard ratio was 0.344 for OS

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us